NCT00446186View on ClinicalTrials.gov

MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)

PHASE2CompletedINTERVENTIONAL
Enrollment

945

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Rhinitis Allergic
Interventions
DRUG

MK0476, montelukast sodium / Duration of Treatment: 2 Weeks

DRUG

Comparator: placebo / Duration of Treatment: 2 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00446186 - MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378) | Biotech Hunter | Biotech Hunter